Literature DB >> 30579630

Engineering hiPSC cardiomyocyte in vitro model systems for functional and structural assessment.

Alison Schroer1, Gaspard Pardon2, Erica Castillo3, Cheavar Blair3, Beth Pruitt3.   

Abstract

The study of human cardiomyopathies and the development and testing of new therapies has long been limited by the availability of appropriate in vitro model systems. Cardiomyocytes are highly specialized cells whose internal structure and contractile function are sensitive to the local microenvironment and the combination of mechanical and biochemical cues they receive. The complementary technologies of human induced pluripotent stem cell (hiPSC) derived cardiomyocytes (CMs) and microphysiological systems (MPS) allow for precise control of the genetics and microenvironment of human cells in in vitro contexts. These combined systems also enable quantitative measurement of mechanical function and intracellular organization. This review describes relevant factors in the myocardium microenvironment that affect CM structure and mechanical function and demonstrates the application of several engineered microphysiological systems for studying development, disease, and drug discovery.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Cardiac mechanobiology; Drug discovery; Heart-on-a-chip; Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs); In vitro cardiac model; Microphysiological systems (MPS)

Mesh:

Year:  2018        PMID: 30579630      PMCID: PMC6919215          DOI: 10.1016/j.pbiomolbio.2018.12.001

Source DB:  PubMed          Journal:  Prog Biophys Mol Biol        ISSN: 0079-6107            Impact factor:   4.799


  217 in total

Review 1.  Endocardial Notch Signaling in Cardiac Development and Disease.

Authors:  Guillermo Luxán; Gaetano D'Amato; Donal MacGrogan; José Luis de la Pompa
Journal:  Circ Res       Date:  2015-12-03       Impact factor: 17.367

Review 2.  Extracellular matrix communication and turnover in cardiac physiology and pathology.

Authors:  Abhijit Takawale; Siva S V P Sakamuri; Zamaneh Kassiri
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

3.  Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities.

Authors:  Yaowen Liu; Tian Xia; Jiaojun Wei; Qingjie Liu; Xiaohong Li
Journal:  Nanoscale       Date:  2017-04-13       Impact factor: 7.790

4.  Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors.

Authors:  Fatima Z Ammarguellat; Philippe O Gannon; Farhad Amiri; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

5.  Connective tissue growth factor and cardiac fibrosis after myocardial infarction.

Authors:  Rachael G Dean; Leanne C Balding; Riccardo Candido; Wendy C Burns; Zemin Cao; Stephen M Twigg; Louise M Burrell
Journal:  J Histochem Cytochem       Date:  2005-06-13       Impact factor: 2.479

Review 6.  Mouse models of long QT syndrome.

Authors:  Guy Salama; Barry London
Journal:  J Physiol       Date:  2006-10-12       Impact factor: 5.182

Review 7.  Human-induced pluripotent stem cell models of inherited cardiomyopathies.

Authors:  Ioannis Karakikes; Vittavat Termglinchan; Joseph C Wu
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

Review 8.  Small mammalian animal models of heart disease.

Authors:  Paula Camacho; Huimin Fan; Zhongmin Liu; Jia-Qiang He
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

9.  Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.

Authors:  Cláudia Correia; Alexey Koshkin; Patrícia Duarte; Dongjian Hu; Ana Teixeira; Ibrahim Domian; Margarida Serra; Paula M Alves
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

Review 10.  Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases.

Authors:  James A Spudich
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

View more
  7 in total

Review 1.  Bioengineering approaches to treat the failing heart: from cell biology to 3D printing.

Authors:  Moran Yadid; Hadas Oved; Eric Silberman; Tal Dvir
Journal:  Nat Rev Cardiol       Date:  2021-08-27       Impact factor: 32.419

2.  Identifying Features of Cardiac Disease Phenotypes Based on Mechanical Function in a Catecholaminergic Polymorphic Ventricular Tachycardia Model.

Authors:  A Stempien; M Josvai; W J de Lange; J J Hernandez; J Notbohm; T J Kamp; H H Valdivia; L L Eckhardt; K R Maginot; J C Ralphe; W C Crone
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

Review 3.  Microphysiological systems: What it takes for community adoption.

Authors:  Passley Hargrove-Grimes; Lucie A Low; Danilo A Tagle
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-25

4.  Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates.

Authors:  Foster Birnbaum; Asuka Eguchi; Gaspard Pardon; Alex C Y Chang; Helen M Blau
Journal:  NPJ Regen Med       Date:  2022-03-18

Review 5.  Microengineered platforms for characterizing the contractile function of in vitro cardiac models.

Authors:  Wenkun Dou; Manpreet Malhi; Qili Zhao; Li Wang; Zongjie Huang; Junhui Law; Na Liu; Craig A Simmons; Jason T Maynes; Yu Sun
Journal:  Microsyst Nanoeng       Date:  2022-02-28       Impact factor: 7.127

Review 6.  Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Pim R R van Gorp; Serge A Trines; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Front Cardiovasc Med       Date:  2020-03-31

7.  Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.

Authors:  Alison Schroer Vander Roest; Chao Liu; Makenna M Morck; Kristina Bezold Kooiker; Gwanghyun Jung; Dan Song; Aminah Dawood; Arnav Jhingran; Gaspard Pardon; Sara Ranjbarvaziri; Giovanni Fajardo; Mingming Zhao; Kenneth S Campbell; Beth L Pruitt; James A Spudich; Kathleen M Ruppel; Daniel Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-15       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.